Brain and Behavior,
Journal Year:
2022,
Volume and Issue:
12(8)
Published: July 14, 2022
Abstract
Objective
To
synthesize
recent
empirical
evidence
for
the
prevention
and
management
of
falls
fear
falling
in
patients
with
Parkinson's
disease
(PD).
Data
source
Database
from
PubMed,
Cochrane
Library,
EMBASE.
Study
design
Systematic
review.
collection
We
searched
EMBASE
databases
studies
published
inception
to
February
27,
2021.
Inclusion
criteria
were
nonreview
articles
on
measures
related
fall
patients.
Principal
findings
selected
45
conducted
in‐depth
research
discussion.
According
causes
PD
patients,
they
divided
into
five
directions,
namely
physical
status,
pre‐existing
conditions,
environment,
medical
care,
cognition.
In
cognitive
domain,
we
focused
falling.
On
above
basis,
constructed
a
model,
which
is
tertiary
health
care
network,
based
The
Johns
Hopkins
Fall
Risk
Assessment
Tool
provide
ideas
clinical
practice
Conclusions
Falls
can
be
reduced
by
effective
management.
Future
are
needed
explore
efficacy
treatment
falls.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: March 20, 2023
Metabolic
abnormalities
lead
to
the
dysfunction
of
metabolic
pathways
and
metabolite
accumulation
or
deficiency
which
is
well-recognized
hallmarks
diseases.
Metabolite
signatures
that
have
close
proximity
subject's
phenotypic
informative
dimension,
are
useful
for
predicting
diagnosis
prognosis
diseases
as
well
monitoring
treatments.
The
lack
early
biomarkers
could
poor
serious
outcomes.
Therefore,
noninvasive
methods
with
high
specificity
selectivity
desperately
needed.
Small
molecule
metabolites-based
metabolomics
has
become
a
specialized
tool
biomarker
pathway
analysis,
revealing
possible
mechanisms
human
various
deciphering
therapeutic
potentials.
It
help
identify
functional
related
variation
delineate
biochemical
changes
indicators
pathological
damage
prior
disease
development.
Recently,
scientists
established
large
number
profiles
reveal
underlying
networks
target
exploration
in
biomedicine.
This
review
summarized
analysis
on
potential
value
small-molecule
candidate
metabolites
clinical
events,
may
better
diagnosis,
prognosis,
drug
screening
treatment.
We
also
discuss
challenges
need
be
addressed
fuel
next
wave
breakthroughs.
MedComm,
Journal Year:
2023,
Volume and Issue:
4(4)
Published: July 31, 2023
Multi-omics
usually
refers
to
the
crossover
application
of
multiple
high-throughput
screening
technologies
represented
by
genomics,
transcriptomics,
single-cell
proteomics
and
metabolomics,
spatial
so
on,
which
play
a
great
role
in
promoting
study
human
diseases.
Most
current
reviews
focus
on
describing
development
multi-omics
technologies,
data
integration,
particular
disease;
however,
few
them
provide
comprehensive
systematic
introduction
multi-omics.
This
review
outlines
existing
technical
categories
multi-omics,
cautions
for
experimental
design,
focuses
integrated
analysis
methods
especially
approach
machine
learning
deep
integration
corresponding
tools,
medical
researches
(e.g.,
cancer,
neurodegenerative
diseases,
aging,
drug
target
discovery)
as
well
open-source
tools
databases,
finally,
discusses
challenges
future
directions
precision
medicine.
With
algorithms,
important
disease
research,
also
provided
detailed
introduction.
will
guidance
researchers,
who
are
just
entering
into
research.
Metabolites,
Journal Year:
2022,
Volume and Issue:
12(2), P. 194 - 194
Published: Feb. 19, 2022
The
metabolome
offers
a
dynamic,
comprehensive,
and
precise
picture
of
the
phenotype.
Current
high-throughput
technologies
have
allowed
discovery
relevant
metabolites
that
characterize
wide
variety
human
phenotypes
with
respect
to
health,
disease,
drug
monitoring,
even
aging.
Metabolomics,
parallel
genomics,
has
led
biomarkers
aided
in
understanding
diversity
molecular
mechanisms,
highlighting
its
application
precision
medicine.
This
review
focuses
on
metabolomics
can
be
applied
improve
as
well
trends
impacts
metabolic
neurodegenerative
diseases,
cancer,
longevity,
exposome,
liquid
biopsy
development,
pharmacometabolomics.
identification
distinct
metabolomic
profiles
will
help
improvement
clinical
strategies
treat
disease.
In
years
come,
become
tool
routinely
diagnose
monitor
health
aging,
or
development.
Biomedical
applications
already
foreseen
progression
such
obesity
diabetes,
using
branched-chain
amino
acids,
acylcarnitines,
certain
phospholipids,
genomics;
these
assess
disease
severity
predict
potential
treatment.
Future
endeavors
should
focus
determining
applicability
utility
metabolomic-derived
markers
their
appropriate
implementation
large-scale
settings.
Chemical Reviews,
Journal Year:
2023,
Volume and Issue:
123(6), P. 2902 - 2949
Published: Feb. 24, 2023
The
investigation
of
macromolecular
biomolecules
with
ion
mobility
mass
spectrometry
(IM-MS)
techniques
has
provided
substantial
insights
into
the
field
structural
biology
over
past
two
decades.
An
IM-MS
workflow
applied
to
a
given
target
analyte
provides
mass,
charge,
and
conformation,
all
three
these
can
be
used
discern
information.
While
charge
are
determined
in
(MS),
it
is
addition
that
enables
separation
isomeric
isobaric
ions
direct
elucidation
which
reaped
huge
benefits
for
biology.
In
this
review,
where
we
focus
on
analysis
proteins
their
complexes,
outline
typical
features
an
experiment
from
preparation
samples,
creation
ions,
different
spectrometers.
We
describe
interpretation
data
terms
protein
conformation
how
compared
other
sources
use
computational
tools.
benefit
coupling
activation
via
collisions
gas
or
surfaces
photons
photoactivation
detailed
reference
recent
examples.
And
finally,
afforded
by
experiments
when
study
conformationally
dynamic
intrinsically
disordered
proteins.
npj Parkinson s Disease,
Journal Year:
2022,
Volume and Issue:
8(1)
Published: May 24, 2022
Parkinson's
disease
(PD)
is
mainly
managed
by
pharmacological
therapy
(e.g.,
Benserazide
and
dopamine
agonists).
However,
prolonged
use
of
these
drugs
would
gradually
diminish
their
dopaminergic
effect.
Gut
dysbiosis
was
observed
in
some
patients
with
PD,
suggesting
close
association
between
the
gut
microbiome
PD.
Probiotics
modulate
host's
microbiota
beneficially.
A
3-month
randomized,
double-blind,
placebo-controlled
clinical
trial
conducted
to
investigate
beneficial
effect
probiotic
co-administration
Eighty-two
PD
were
recruited
randomly
divided
into
[n
=
48;
Bifidobacterium
animalis
subsp.
lactis
Probio-M8
(Probio-M8),
Benserazide,
agonists]
placebo
(n
34;
placebo,
agonists)
groups.
Finally,
45
29
from
groups
provided
complete
fecal
serum
samples
for
further
omics
analysis,
respectively.
The
results
showed
that
conferred
added
benefits
improving
sleep
quality,
alleviating
anxiety,
gastrointestinal
symptoms.
Metagenomic
analysis
that,
after
intervention,
there
significantly
more
species-level
genome
bins
(SGBs)
animalis,
Ruminococcaceae,
Lachnospira,
while
less
Lactobacillus
fermentum
Klebsiella
oxytoca
group
(P
<
0.05).
Interestingly,
correlated
positively
scores
UPDRS-III,
HAMA,
HAMD-17,
negatively
MMSE.
feces
hardness.
Moreover,
co-administering
increased
SGBs
involved
tryptophan
degradation,
gamma-aminobutyric
acid,
short-chain
fatty
acids,
secondary
bile
acid
biosynthesis,
as
well
acetic
levels
Taken
together,
synergized
conventional
regimen
strengthened
efficacy
managing
accompanied
modifications
microbiome,
microbial
metabolic
potential,
metabolites.
Neurobiology of Disease,
Journal Year:
2024,
Volume and Issue:
196, P. 106505 - 106505
Published: April 19, 2024
Alzheimer's
and
Parkinson's
diseases
are
two
of
the
most
frequent
neurological
diseases.
The
clinical
features
AD
memory
decline
cognitive
dysfunction,
while
PD
mainly
manifests
as
motor
dysfunction
such
limb
tremors,
muscle
rigidity
abnormalities,
slow
gait.
Abnormalities
in
cholesterol,
sphingolipid,
glycerophospholipid
metabolism
have
been
demonstrated
to
directly
exacerbate
progression
by
stimulating
Aβ
deposition
tau
protein
tangles.
Indirectly,
abnormal
lipids
can
increase
burden
on
brain
vasculature,
induce
insulin
resistance,
affect
structure
neuronal
cell
membranes.
Abnormal
lipid
leads
through
inducing
accumulation
α-syn,
mitochondria
endoplasmic
reticulum,
ferroptosis.
Great
progress
has
made
targeting
abnormalities
for
treatment
recent
years,
like
metformin,
insulin,
peroxisome
proliferator-activated
receptors
(PPARs)
agonists,
monoclonal
antibodies
apolipoprotein
E
(ApoE).
This
review
comprehensively
summarizes
involvement
dysregulated
pathogenesis
PD,
application
Lipid
Monitoring,
emerging
regulatory
drug
targets.
A
better
understanding
lipidological
bases
may
pave
way
developing
effective
prevention
methods
neurodegenerative
disorders.
Cellular and Molecular Life Sciences,
Journal Year:
2021,
Volume and Issue:
78(19-20), P. 6487 - 6503
Published: Aug. 19, 2021
During
the
past
decade
metabolomics
has
emerged
as
one
of
fastest
developing
branches
"-omics"
technologies.
Metabolomics
involves
documentation,
identification,
and
quantification
metabolites
through
modern
analytical
platforms
in
various
biological
systems.
Advanced
tools,
such
gas
chromatography-mass
spectrometry
(GC/MS),
liquid
spectroscopy
(LC/MS),
non-destructive
nuclear
magnetic
resonance
(NMR)
spectroscopy,
have
facilitated
metabolite
profiling
complex
matrices.
Metabolomics,
along
with
transcriptomics,
an
influential
role
discovering
connections
between
genetic
regulation,
phenotyping
biomarkers
identification.
Comprehensive
allows
integration
summarized
data
towards
manipulation
biosynthetic
pathways,
determination
nutritional
quality
markers,
improvement
crop
yield,
selection
desired
metabolites/genes,
their
heritability
breeding.
Along
that,
is
invaluable
predicting
activity
medicinal
plants,
assisting
bioactivity-guided
fractionation
process
bioactive
leads
discovery,
well
serving
a
tool
for
control
authentication
commercial
plant-derived
natural
products.
Metabolomic
analysis
human
biofluids
implemented
clinical
practice
to
discriminate
physiological
pathological
state
humans,
aid
early
disease
biomarker
discovery
predict
individual
response
drug
therapy.
Thus,
could
be
utilized
preserve
health
by
improving
crops
accelerating
diagnostics,
or
increasing
therapeutic
efficacy
drugs
via
more
personalized
approach.
Here,
we
attempt
explore
potential
value
comprising
above-mentioned
applications
improvement,
plants
utilization,
and,
prognosis,
diagnosis
management
diseases.
ACS Nano,
Journal Year:
2022,
Volume and Issue:
16(7), P. 11204 - 11217
Published: July 6, 2022
Nanoscale
sulfur
can
be
a
multifunctional
agricultural
amendment
to
enhance
crop
nutrition
and
suppress
disease.
Pristine
(nS)
stearic
acid
coated
(cS)
nanoparticles
were
added
soil
planted
with
tomatoes
(Solanum
lycopersicum)
at
200
mg/L
infested
Fusarium
oxysporum.
Bulk
sulfur,
ionic
sulfate,
healthy
controls
included.
Orthogonal
end
points
measured
in
two
greenhouse
experiments,
including
agronomic
photosynthetic
parameters,
disease
severity/suppression,
mechanistic
biochemical
molecular
the
time-dependent
expression
of
13
genes
related
S
bioassimilation
pathogenesis-response,
metabolomic
profiles.
Disease
reduced
plant
biomass
by
up
87%,
but
nS
cS
significantly
as
determined
area-under-the-disease-progress
curve
54
56%,
respectively.
An
increase
planta
accumulation
was
evident,
size-specific
translocation
ratios
suggesting
different
uptake
mechanisms.
In
vivo
two-photon
microscopy
gene
revealed
nanoscale-specific
elemental
pathway
within
that
is
separate
from
traditional
sulfate
accumulation.
These
findings
correlate
well
profiling,
which
exhibited
increased
resistance
immunity
metabolites
only
nanoscale
treatment.
The
linked
metabolomics
data
demonstrate
time-sensitive
physiological
window
where
stimulation
will
effective.
provide
understandings
nonmetal
nanomaterial-based
suppression
advance
sustainable
nanoenabled
strategies
food
production.
Acta Neuropathologica,
Journal Year:
2023,
Volume and Issue:
146(3), P. 369 - 385
Published: July 8, 2023
The
accumulation
of
proteinaceous
inclusions
in
the
brain
is
a
common
feature
among
neurodegenerative
diseases
such
as
Alzheimer's
disease,
Parkinson's
disease
(PD),
and
dementia
with
Lewy
bodies
(DLB).
main
neuropathological
hallmark
PD
DLB
are
inclusions,
known
(LBs),
enriched
not
only
α-synuclein
(aSyn),
but
also
lipid
species,
organelles,
membranes,
even
nucleic
acids.
Furthermore,
several
genetic
risk
factors
for
mutations
genes
involved
metabolism,
GBA1,
VSP35,
or
PINK1.
Thus,
it
surprising
that
mechanisms
have
been
implicated
PD,
inflammation,
altered
intracellular
vesicular
trafficking,
mitochondrial
dysfunction,
alterations
protein
degradation
systems,
may
be
directly
indirectly
connected
through
homeostasis.
In
this
review,
we
highlight
discuss
recent
evidence
suggests
biology
important
drivers
which
require
renovated
attention
by
neuropathologists.
Particularly,
address
implication
lipids
aSyn
spreading
pathology,
ER
stress.
Together,
should
broaden
view
proteinopathy
lipidopathy.
Science Bulletin,
Journal Year:
2023,
Volume and Issue:
68(19), P. 2268 - 2284
Published: Aug. 29, 2023
Metabolomics
is
a
nascent
field
of
inquiry
that
emerged
in
the
late
20th
century.
It
encompasses
comprehensive
profiling
metabolites
across
spectrum
organisms,
ranging
from
bacteria
and
cells
to
tissues.
The
rapid
evolution
analytical
methods
data
analysis
has
greatly
accelerated
progress
this
dynamic
discipline
over
recent
decades.
Sophisticated
techniques
such
as
liquid
chromatograph
mass
spectrometry
(MS),
gas
MS,
capillary
electrophoresis
nuclear
magnetic
resonance
serve
cornerstone
metabolomic
analysis.
Building
upon
these
methods,
plethora
modifications
combinations
have
propel
advancement
metabolomics.
Despite
progress,
scrutinizing
metabolism
at
single-cell
or
single-organelle
level
remains
an
arduous
task
Some
most
thrilling
advancements,
metabolic
techniques,
offer
profound
insights
into
intricate
mechanisms
within
organelles.
This
allows
for
study
heterogeneity
its
pivotal
role
multiple
biological
processes.
made
MS
imaging
enabled
high-resolution
situ
tissue
sections
even
individual
cells.
Spatial
reconstruction
enable
direct
representation
distribution
alteration
three-dimensional
space.
application
novel
led
significant
breakthroughs
clinical
studies,
including
discovery
pathways,
determination
cell
fate
differentiation,
anti-aging
intervention
through
modulating
metabolism,
metabolomics-based
clinicopathologic
analysis,
surgical
decision-making
based
on
on-site
intraoperative
review
presents
overview
both
conventional
innovative
highlighting
their
applications
groundbreaking
studies.